The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers
use clinical data and human biospecimens to investigate why scleroderma patients develop
certain complications from their disease. Patients with confirmed scleroderma, raynauds or
positive autoantibodies are invited to participate. This research may help us understand how
to prevent and treat scleroderma and other diseases.